Occult neovascular membrane in central serous chorioretinopathy
Author: Miriam Rahhal (Spain)
Co-authors: Teresa Diago-Sempere
Purpose
To highlight the importance of OCT-A imaging in patients with acute vision loss diagnosed with central serous chorioretinopathy (CSC).
Setting/Venue
A case report of a young male patient diagnosed with CSC reporting acute vision loss and treated with aflibercept intravitreal injections is presented.
Methods
A 39-year-old male patient attended our Ophthalmology Clinic due to subacute vision loss in his right eye. He had been diagnosed with central serous chorioretinopathy in another ophthalmological centre but had received no treatment. Visual acuity was 0.8/1.0 according to Snellen’s visual acuity chart. Anterior segment slit lamp examination showed no pathological findings. Fundus examination showed retinal pigment epithelium changes. Structural OCT showed pigment epithelium detachment (PED) associated with subretinal fluid in his right eye. Central macular thickness (CMT) was 288. OCT angiography (OCT-A) was performed and an occult neovascular membrane (NVM) in the inner surface of the PED was observed. Central serous chorioretinopathy with complicated NV diagnosis was made. Aflibercept injections were administered.
Results
After the first aflibercept injection, an improvement in right eye’s visual acuity (visual acuity went from 0.8 to 1.0) and CMT were observed (from 288 to 241).
Conlusions
Various conclusions can be drawn from this case. Aflibercept has been shown to be effective in NVM secondary to CSC. In addition, this case highlights the importance of implementing OCT-A imaging in diagnostic protocols involving CSC, especially when patients refer vision loss, in order to reveal occult NVM and be able to administer an effective treatment as early as possible avoiding chronic vision loss in these patients.